{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["8(1)"],"submitter":["Sani MU"],"pubmed_abstract":["<h4>Aims</h4>The relationship between N-terminal pro-brain natriuretic peptide (NT-pro-BNP) and galectin-3 and outcomes has not been studied in African patients with acute heart failure (AHF). The current analysis sought to describe the association between plasma levels of NT-pro-BNP and galectin-3 and cardiovascular (CV) death or heart failure (HF) hospitalization, as well as their associations with symptoms and echocardiography markers of left and right ventricular remodelling among AHF patientsv in sub-Saharan Africa.<h4>Methods and results</h4>In a subset of 80 patients with complete data in a study assessing the effects of hydralazine and nitrates in patients with AHF (BAHEF trial; NCT01822808), NT-pro-BNP and galectin-3 analyses were performed, and the association with various charac"],"journal":["ESC heart failure"],"pagination":["74-84"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7835570"],"repository":["biostudies-literature"],"pubmed_title":["N-terminal pro BNP and galectin-3 are prognostic biomarkers of acute heart failure in sub-Saharan Africa: lessons from the BAHEF trial."],"pmcid":["PMC7835570"],"pubmed_authors":["Damasceno A","Mayosi BM","Edwards C","Azibani F","Sani MU","Cotter G","Arif G","Davison BA","Adam T","Sliwa K","Jessen N"],"additional_accession":[]},"is_claimable":false,"name":"N-terminal pro BNP and galectin-3 are prognostic biomarkers of acute heart failure in sub-Saharan Africa: lessons from the BAHEF trial.","description":"<h4>Aims</h4>The relationship between N-terminal pro-brain natriuretic peptide (NT-pro-BNP) and galectin-3 and outcomes has not been studied in African patients with acute heart failure (AHF). The current analysis sought to describe the association between plasma levels of NT-pro-BNP and galectin-3 and cardiovascular (CV) death or heart failure (HF) hospitalization, as well as their associations with symptoms and echocardiography markers of left and right ventricular remodelling among AHF patientsv in sub-Saharan Africa.<h4>Methods and results</h4>In a subset of 80 patients with complete data in a study assessing the effects of hydralazine and nitrates in patients with AHF (BAHEF trial; NCT01822808), NT-pro-BNP and galectin-3 analyses were performed, and the association with various charac","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Feb","modification":"2025-04-26T02:25:54.582Z","creation":"2021-02-21T05:28:48Z"},"accession":"S-EPMC7835570","cross_references":{"pubmed":["33247624"],"doi":["10.1002/ehf2.13032"]}}